TY - JOUR
T1 - Identification and management of prediabetes
T2 - Results of the Latin America Strategic Prediabetes Meeting
AU - López-Jaramillo, Patricio
AU - Nieto-Martínez, Ramfis E.
AU - Aure-Fariñez, Gestne
AU - Mendivil, Carlos O.
AU - Lahsen, Rodolfo A.
AU - Silva-Filho, Ruy L.
AU - Andreotti, Luiz A.
AU - Manrique, Mónica E.
AU - Pasquel-Andrade, Miguel A.
AU - Rangel, Ignacio
AU - Vidrio, Maricela
AU - Castañeda, Rutila
AU - Restrepo, Manuela
AU - Pinto, Miguel E.
N1 - Publisher Copyright:
© 2017 Pan American Health Organization. All rights reserved.
PY - 2017
Y1 - 2017
N2 - To understand the status of prediabetes diagnosis and treatment in Latin America and to evaluate the use of metformin for diabetes prevention in this context. A panel of 15 diabetes experts from seven countries in Latin America met on 14 - 15 August 2014 in Lima, Peru, to review the available literature, discuss the role of prediabetes in type 2 diabetes mellitus and cardiovascular disease, analyze collected information, and make conclusions for prediabetes diagnosis and treatment in Latin America. Prediabetes diagnosis, screening, and treatment, including lifestyle changes, pharmacological treatment, and cost-effectiveness were discussed. Five resulting statements were issued for Latin America: prediabetes is a clinical and public health problem; health care systems do not currently diagnose/treat prediabetes; use of prediabetes risk detection tools are needed region-wide; treatment includes lifestyle changes, multidisciplinary education, and metformin; and registries of patient records and further studies should be supported. The expert panel concluded that in Latin America, preventive treatment through lifestyle changes and metformin are cost-effective interventions. It is important to improve prediabetes identification and management at the primary care level.
AB - To understand the status of prediabetes diagnosis and treatment in Latin America and to evaluate the use of metformin for diabetes prevention in this context. A panel of 15 diabetes experts from seven countries in Latin America met on 14 - 15 August 2014 in Lima, Peru, to review the available literature, discuss the role of prediabetes in type 2 diabetes mellitus and cardiovascular disease, analyze collected information, and make conclusions for prediabetes diagnosis and treatment in Latin America. Prediabetes diagnosis, screening, and treatment, including lifestyle changes, pharmacological treatment, and cost-effectiveness were discussed. Five resulting statements were issued for Latin America: prediabetes is a clinical and public health problem; health care systems do not currently diagnose/treat prediabetes; use of prediabetes risk detection tools are needed region-wide; treatment includes lifestyle changes, multidisciplinary education, and metformin; and registries of patient records and further studies should be supported. The expert panel concluded that in Latin America, preventive treatment through lifestyle changes and metformin are cost-effective interventions. It is important to improve prediabetes identification and management at the primary care level.
KW - Diabetes
KW - Diabetes mellitus
KW - Latin America
KW - Prediabetic state
KW - Prevention & control
KW - Type 2
UR - http://www.scopus.com/inward/record.url?scp=85040978740&partnerID=8YFLogxK
U2 - 10.26633/RPSP.2017.172
DO - 10.26633/RPSP.2017.172
M3 - Articulo en revista no especializada
AN - SCOPUS:85040978740
SN - 1020-4989
VL - 41
JO - Revista Panamericana de Salud Publica/Pan American Journal of Public Health
JF - Revista Panamericana de Salud Publica/Pan American Journal of Public Health
M1 - e172
ER -
